Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
Cash from Operating Activities
Bio Rad Laboratories Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bio Rad Laboratories Inc
NYSE:BIO
|
Cash from Operating Activities
$374.9m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Operating Activities
$8.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Operating Activities
$965.9m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Operating Activities
$2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
See Also
What is Bio Rad Laboratories Inc's Cash from Operating Activities?
Cash from Operating Activities
374.9m
USD
Based on the financial report for Dec 31, 2023, Bio Rad Laboratories Inc's Cash from Operating Activities amounts to 374.9m USD.
What is Bio Rad Laboratories Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
8%
Over the last year, the Cash from Operating Activities growth was 93%. The average annual Cash from Operating Activities growth rates for Bio Rad Laboratories Inc have been -14% over the past three years , 6% over the past five years , and 8% over the past ten years .